教育经历
2018/09-2021/07,雷竞技raybat下载,Ray雷竞技官网,药剂学,博士
2015/09-2018/07,雷竞技raybat下载,Ray雷竞技官网,工业药学,硕士
工作经历
2024/07-至今,雷竞技raybat下载,Ray雷竞技官网,副研究员
2021/07-2024/07,雷竞技raybat下载,Ray雷竞技官网,博士后
1. 智能递药系统与氧化还原调控
2. 肿瘤微环境代谢调控与铁死亡靶向干预
1. 国家自然科学基金青年科学基金项目(82302367):酶促可控超氧自由基生成器用于肿瘤特异性级联催化治疗及其机制研究,2024.01-2026.12,30万元,在研,主持;
2. 江苏省自然科学基金青年基金项目(BK20231019):胶原穿透型脂质体诱导肿瘤干细胞铁死亡的抗乳腺癌转移研究,2023.09-2026.08,20万元,在研,主持;
3. 中国博士后科学基金派出项目:Investigation of nanomaterials and their effects on tumor Microenvironment,30万元,结题,主持;
4. 江苏省卓越博士后项目:调控乳酸代谢的化学动力学加速器治疗转移性肿瘤的研究,30万元,结题,主持;
5. 中国博士后科学基金第70批面上资助(2021M703598):催化乳酸代谢诱导铁死亡的纳米反应器在转移性乳腺癌治疗中的应用,2022.01-2023.12,8万元,结题,主持;
6. 雷竞技raybat下载基本科研业务费重点项目(2632026ZD03):基于乳酸-衰老轴调控巨噬细胞衰老的三阴性乳腺癌治疗研究,2026-2028,25万元,在研,主持。
1. Zhou TJ#, Liu DM#, Yu HQ#, Zhang MM, Che HB, Wang Y, Cheng XW*, Xing L*, Jiang HL*, Spatiotemporal Regulation of Oxidative Stress by Redox Relays for Ischemia-Reperfusion Injury Rescue, Advanced Functional Materials. 2026, 36, 6, e13467.
2. Zhou TJ#, Zhang MM#, Liu DM#, Huang LL, Yu HQ, Wang Y, Xing L*, Jiang HL*, Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer. Biomaterials. 2024, 305, 122447.
3. Zhou TJ#, Wan X#, Zhang MM#, Liu DM, Huang LL, Xing L, Wang Y*, Jiang HL*, Tumor microenvironment-initiated lipid redox cycling for efficient triple-negative breast cancer therapy. Biomaterials.2023, 300, 122205
4. Han H#, Chen BT#, Liu Y#, Wang Y, Xing L, Wang H, Zhou TJ*, Jiang HL*, Engineered stem cell-based strategy: A new paradigm of next-generation stem cell product in regenerative medicine. Journal of Controlled Release. 2024, 365, 981-1003.
5. Yang MY#, Lin YJ#, Han MM, Bi YY, He XY, Xing L, Jeong JJ, Zhou TJ*, Jiang HL*. Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy. Journal of Controlled Release. 2022, 351, 623-637.
6. Zhou TJ#, Xu Y#, Gong YH#, Yu MT, Xu EZ, Aimaiti W, Ma RJ, Xing Lei, Wen Hao*, Wang JH*, Jiang HL*. Breaking-then-curing strategy for efficient cystic echinococcosis therapy. Chinese Chemical Letters. 2022, 33(6): 2949-2953.
7. Zhou TJ, Xu Y, Xing L, Wang Y, Jiang HL*. A harmless-harmful switchable and uninterrupted laccase-instructed killer for activatable chemodynamic therapy. Advanced Materials. 2021;33:e00114.


